Epstein-Barr Virus-Transformed Human B Lymphocytes Endocytose Autologous and Heterologous Red Blood Cells

1989 ◽  
Vol 88 (3) ◽  
pp. 312-316
Author(s):  
Carlo Garzelli ◽  
Antonio Marchetti ◽  
Anna Pacciardi ◽  
Carla Puglisi ◽  
Fulvio Basolo
Transfusion ◽  
2005 ◽  
Vol 45 (4) ◽  
pp. 591-595 ◽  
Author(s):  
Lirong Qu ◽  
Shushen Xu ◽  
David Rowe ◽  
Darrell Triulzi

Vaccines ◽  
2021 ◽  
Vol 9 (3) ◽  
pp. 285
Author(s):  
Xinle Cui ◽  
Zhouhong Cao ◽  
Yuriko Ishikawa ◽  
Sara Cui ◽  
Ken-Ichi Imadome ◽  
...  

Epstein–Barr virus (EBV) is the primary cause of infectious mononucleosis and is strongly implicated in the etiology of multiple lymphoid and epithelial cancers. EBV core fusion machinery envelope proteins gH/gL and gB coordinately mediate EBV fusion and entry into its target cells, B lymphocytes and epithelial cells, suggesting these proteins could induce antibodies that prevent EBV infection. We previously reported that the immunization of rabbits with recombinant EBV gH/gL or trimeric gB each induced markedly higher serum EBV-neutralizing titers for B lymphocytes than that of the leading EBV vaccine candidate gp350. In this study, we demonstrated that immunization of rabbits with EBV core fusion machinery proteins induced high titer EBV neutralizing antibodies for both B lymphocytes and epithelial cells, and EBV gH/gL in combination with EBV trimeric gB elicited strong synergistic EBV neutralizing activities. Furthermore, the immune sera from rabbits immunized with EBV gH/gL or trimeric gB demonstrated strong passive immune protection of humanized mice from lethal dose EBV challenge, partially or completely prevented death respectively, and markedly decreased the EBV load in peripheral blood of humanized mice. These data strongly suggest the combination of EBV core fusion machinery envelope proteins gH/gL and trimeric gB is a promising EBV prophylactic vaccine.


1994 ◽  
Vol 269 (29) ◽  
pp. 18743-18746 ◽  
Author(s):  
F.E. Maly ◽  
L.A. Quilliam ◽  
O. Dorseuil ◽  
C.J. Der ◽  
G.M. Bokoch

2014 ◽  
Vol 58 (2-3) ◽  
pp. 268-276 ◽  
Author(s):  
Olivia L. Hatton ◽  
Aleishia Harris-Arnold ◽  
Steven Schaffert ◽  
Sheri M. Krams ◽  
Olivia M. Martinez

Author(s):  
David Liebowitz ◽  
Elliott Kieff ◽  
Jeffery Sample ◽  
Mark Birkenbach ◽  
Fred Wang

2021 ◽  
Author(s):  
Neeraj Sharma ◽  
Rajat Shukla ◽  
Rachna Warrier ◽  
Kunal Kumar ◽  
Nalin Singh ◽  
...  

Abstract Pancytopenia is a condition when person has low count of all three types of blood cells causing a triage of anemia, leukopenia and thrombocytopenia. It should not be considered as a disease in itself but rather the sign of a disease that needs to be further evaluated. Among the various causes, viral infections like Human Immunodeficiency Virus, Cytomegalovirus, Epstein-Barr virus and Parvovirus B19 have been implicated. Pancytopenia is a rare complication and not commonly seen in patients with COVID 19 disease. Here, we report a case of pancytopenia in previously immunocompetent elderly male patient with SARS-CoV2 infection.


Sign in / Sign up

Export Citation Format

Share Document